HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MK0767

dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities
Also Known As:
5-((2,4-dioxothiazolidin-5-yl)-2-methoxy-N-((4-trifluoromethyl)phenyl)methyl)benzamide; MK-0767
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Franklin, Ronald B: 3 articles (09/2006 - 01/2004)
2. Rippley, Ronda K: 2 articles (03/2007 - 09/2006)
3. Yan, Kerri X: 2 articles (03/2007 - 09/2006)
4. Vincent, Stella H: 2 articles (09/2006 - 01/2004)
5. Bakhtiar, Ray: 2 articles (01/2005 - 01/2004)
6. Shen, Zhongzhou: 2 articles (01/2005 - 01/2004)
7. Greenberg, Howard E: 1 article (03/2007)
8. Herman, Gary A: 1 article (03/2007)
9. Matthews, Natalie D: 1 article (03/2007)
10. Wagner, John A: 1 article (03/2007)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Dyslipidemias (Dyslipidemia)
3. Hyperinsulinism (Hyperinsulinemia)
4. Hyperglycemia

Related Drugs and Biologics

1. Peroxisome Proliferator-Activated Receptors (PPAR)
2. PPAR alpha
3. benzamide
4. 2,4-thiazolidinedione (thiazolidinedione)
5. Pioglitazone (Actos)
6. 5- ((2,4- dioxo- 5- thiazolidinyl)methyl)- 2- methoxy- N- ((4- (trifluoromethyl)phenyl)methyl)benzamide